女性绝育手术市场（2026—2031）
女性绝育手术市场预计从2026年的96.4亿美元增至2031年的123.7亿美元，预测期复合年增长率为5.12%。北美保持最大市场地位，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
女性绝育手术市场预计从2026年的96.4亿美元增至2031年的123.7亿美元，预测期复合年增长率为5.12%。北美保持最大市场地位，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 5.12% | 机构预测 |
| 市场规模 | 2026 | USD 9.64 billion | 机构预测 |
| 市场规模 | 2031 | USD 12.37 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| end_user | hospitals and maternity centers | 2025 | 64.760% |
| geography | North America | 2025 | 42.430% |
| procedure_type | surgical sterilization | 2025 | 63.540% |
关键结论
- end_user 维度中，hospitals and maternity centers 在 2025 年的公开份额为 64.76%。
- geography 维度中，North America 在 2025 年的公开份额为 42.43%。
- procedure_type 维度中，surgical sterilization 在 2025 年的公开份额为 63.54%。
主要参与者
- Planned Parenthood Federation of America
- MSI Reproductive Choices
- EngenderHealth
- International Planned Parenthood Federatio
- Apollo Hospitals Enterprise Limited
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Expanding Access to Permanent Contraception | +1.200% | Global, concentrated in South Asia, Sub-Saharan Africa, and Latin America | Medium term (2-4 years) |
| Government-Supported Family-Planning Programs | +0.900% | South Asia, Sub-Saharan Africa, and Latin America, with lower support in aid-dependent settings | Short term (≤ 2 years) |
| Shift Toward Minimally Invasive and Outpatient Procedures | +1.400% | North America, Europe, and urban Asia-Pacific | Long term (≥ 4 years) |
| Rising Reproductive Autonomy and Sterilization Awareness | +0.600% | North America, Europe, and urban Asia-Pacific | Long term (≥ 4 years) |
| Postpartum and Cesarean-Delivery Integration | +0.500% | North America, Europe, and Asia-Pacific | Medium term (2-4 years) |
| Opportunistic Salpingectomy for Ovarian-Cancer Risk Reduction | +0.700% | North America, Europe, Asia-Pacific, and other global settings | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Irreversibility, Regret, and Informed-Consent Requirements | -0.900% | North America and Europe, with higher risk among younger and lower-income populations | Long term (≥ 4 years) |
| Competition from Long-Acting Reversible Contraception | -1.100% | North America, Europe, and urban Asia-Pacific | Medium term (2-4 years) |
| Unequal Surgical Capacity and Reimbursement Access | -0.700% | Sub-Saharan Africa, rural Asia-Pacific, and Latin America | Medium term (2-4 years) |
| Historical Device-Safety Concerns and Trust Deficits | -0.400% | Global, concentrated in locations where transcervical devices were sold | Long term (≥ 4 years) |
报告关注的关键问题
What is driving growth in female sterilization procedures?
The female sterilization procedures market is supported by greater access to permanent contraception, outpatient care, and salpingectomy for ovarian cancer risk reduction.
How large is the female sterilization procedures market?
The market is projected to grow from USD 9.64 billion in 2026 to USD 12.37 billion by 2031 at a 5.12% CAGR.
Which procedure type leads demand?
Surgical sterilization led with 63.54% of procedure volume in 2025 and is projected to grow at a 7.54% CAGR through 2031.
Why are ambulatory surgical centers gaining relevance?
Ambulatory surgical centers are projected to grow at an 8.12% CAGR as more procedures move to outpatient settings.
Which region is growing fastest?
Asia-Pacific is projected to grow at a 6.54% CAGR through 2031, led by India's large role in permanent contraception use.
How do LARC methods affect permanent contraception choices?
LARC use reached 10.5% in the United States in 2022 and 2023, close to the 11.5% prevalence of female sterilization.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence